Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nour Heart Therapeutics
Hartford, Connecticut, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Nour Heart is developing (1) a blood-based diagnostic for early myocardial ischemia (“Nourin miRNAs”) for rapid rule-in/rule-out of ischemia in chest pain patients, with focus on earlier detection than current standards and special benefit for women; and (2) Nourexal (Cyclocreatine Phosphate), a novel bioenergetic drug with FDA Orphan Drug Designation for heart transplantation. Published data highlight preclinical proof of concept and readiness for Phase 1/2 clinical safety testing, but no published late-stage clinical results yet.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small moleculeDiagnostic (Molecular Biomarker)Biologic (miRNA diagnostic)Small molecule conjugate (Cyclocreatine Phosphate)
- Industry
- Biotech
02
Partnerships
Collaboration with University of Connecticut School of Medicine (academic; Dr. Elgebaly is adjunct faculty/GI)Egyptian Academy of Scientific Research and Technology in conjunction with Cairo University and Helwan University (research grant collaboration)
Beyond the preview
Go deeper on Nour Heart Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nour Heart Therapeutics.